Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Fish and Richardson
QuintilesIMS
Fuji
Citi
Johnson and Johnson
Accenture
Teva

Generated: May 26, 2018

DrugPatentWatch Database Preview

MENTAX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Mentax patents expire, and what generic alternatives are available?

Mentax is a drug marketed by Mylan and is included in two NDAs.

The generic ingredient in MENTAX is butenafine hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Drug patent expirations by year for MENTAX
Pharmacology for MENTAX
Ingredient-typeBenzylamines
Drug ClassBenzylamine Antifungal
Synonyms for MENTAX
(4-tert-Butyl-benzyl)-methyl-naphthalen-1-ylmethyl-amine
(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanaminium chloride
[(4-tert-butylphenyl)methyl](methyl)(naphthalen-1-ylmethyl)amine
1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthalenylmethyl)methanamine hydrochloride
1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine
1-(4-tert-butylphenyl)-N-methyl-N-(1-naphthylmethyl)methanamine hydrochloride
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine hydrochloride
1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine; Butenafin
1-Naphthalenemethanamine,N-[[4-(1,1-dimethylethyl)phenyl]methyl]-N-methyl-
101827-46-7
101828-21-1
4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine
4-tert-butylbenzyl(methyl)(1-naphthalenemethyl)amine hydrochloride
4-tert-Butylbenzyl(methyl)(1-naphthalenemethyl)amine;4-tert-Butylbenzyl(methyl)(1-naphthalenemethyl)amine
827B467
828B211
91Y494NL0X
A800463
A800464
AB00053744_03
AB00053744-02
AB0013406
AB0106850
AB07686
ABJKWBDEJIDSJZ-UHFFFAOYSA-N
AC-13296
AC-2116
AC1L1DS8
AC1L9FCX
AKOS015894905
AKOS015895328
AN-14303
AN-34252
ANW-42439
API0001791
API0001792
AS-13357
BC205781
BCP9000464
BDBM50436713
BG0596
BIDD:GT0236
Butenafin
Butenafina
Butenafina [INN-Spanish]
butenafine
Butenafine (Hydrochloride)
Butenafine (INN)
Butenafine [INN:BAN]
Butenafine [INN]
Butenafine HCL
Butenafine hydrochloide
Butenafine hydrochloride
Butenafine hydrochloride (JP17/USAN)
Butenafine hydrochloride [USAN:JAN]
Butenafine hydrochloride, >=98% (HPLC)
Butenafinum
Butenafinum [INN-Latin]
BUTOP
Butop (TN)
C-19529
C08067
C12490
C23H27N
CAS-101827-46-7
CAS-101828-21-1
CC-25279
CC-25280
CCG-220604
CHEBI:31325
CHEBI:3238
CHEMBL1200397
CHEMBL990
CS-1124
CTK8B3383
CTK8E8391
D01093
D07596
D0B4DC
DB01091
DivK1c_007016
DL-101
DR001382
DSSTox_CID_20657
DSSTox_CID_28515
DSSTox_GSID_40657
DSSTox_GSID_48589
DSSTox_RID_79525
DSSTox_RID_82787
DTXSID2048589
DTXSID7040657
FT-0631017
FT-0631018
FT-0699734
H989
HMS2089O04
HY-17396
I06-0093
I06-0721
J-000499
J-000500
K-0256
KBio1_001960
KBio2_002033
KBio2_004601
KBio2_007169
KBioSS_002033
KP 363
KP-363
KP-363|||Mentax|||1-(4-tert-Butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine
KS-00000FUA
KS-1035
LJBSAUIFGPSHCN-UHFFFAOYSA-N
Lotrimin Ultra
LS-171795
Mentax (TN)
Mentax-TC
MLS003899213
MolPort-002-885-811
MolPort-005-934-229
N-((4-(1,1-Dimethylethyl)phenyl)methyl)-N-methyl-1-naphthalenemethanamine hydrochloride
N-(4-(tert-butyl)benzyl)-N-methyl-1-(naphthalen-1-yl)methanamine hydrochloride
N-(4-t-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride;N-(4-t-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride
N-(4-TERT-BUTYLBENZYL)-N-METHYL-1-NAPHTHALENEMETHYLAMINE HYDROCHLORIDE
N-(4-tert-Butylbenzyl)-N-methyl-1-naphthylmethylamin
N-(4-tert-Butylbenzyl)-n-methyl-1-naphthylmethylamine
N-(4-tert-butylbenzyl)-N-methyl-1-naphthylmethylamine hydrochloride
N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine
N-(p-tert-Butylbenzyl)-N-methyl-1-naphthalenemethylamine hydrochloride
N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-N-methyl-1-naphthalenemethanamine hydrochloride
N-4-t-butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride
N-4-tert-butylbenzyl-N-methyl-1-naphthalene methylamine hydrochloride
N-4-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine hydrochloride
N-methyl-N-(4'-t-butylbenzyl)-1-naphthylmethylamine
N-p-tert-Butylbenzyl-N-methyl-1-naphthalenemethylamine
NCGC00159511-02
NCGC00159511-03
NCGC00159511-04
OR193990
R8XA2029ZI
RT-011833
RTR-000443
s3154
SC-17331
SC-17334
SCHEMBL262301
SCHEMBL65526
Scorba
SMR002204106
SpecPlus_000920
Spectrum_001553
ST51052828
SureCN1648813
Tox21 111729
Tox21_111729
Tox21_111729_1
Tox21_112918
TR-000443
UNII-91Y494NL0X
UNII-R8XA2029ZI
VA10450
Volley
Volley (TN)
X5950
ZINC1530975

US Patents and Regulatory Information for MENTAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan MENTAX butenafine hydrochloride CREAM;TOPICAL 020524-001 Oct 18, 1996 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan MENTAX-TC butenafine hydrochloride CREAM;TOPICAL 021408-001 Oct 17, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
Healthtrust
Harvard Business School
Baxter
Citi
Teva
Covington
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.